Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 113

1.

Molecular diagnosis of MODY3 permitted to reveal a de novo 12q24.31 deletion and to explain a complex phenotype in a young diabetic patient.

Iafusco F, De Sanctis P, Pirozzi D, Capone S, Lombardo B, Gambale A, Confetto S, Zanfardino A, Iolascon A, Pastore L, Iafusco D, Tinto N.

Clin Chem Lab Med. 2019 Jun 11. pii: /j/cclm.ahead-of-print/cclm-2019-0137/cclm-2019-0137.xml. doi: 10.1515/cclm-2019-0137. [Epub ahead of print] No abstract available.

PMID:
31188748
2.

Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.

Green CA, Sande CJ, Scarselli E, Capone S, Vitelli A, Nicosia A, Silva-Reyes L, Thompson AJ, de Lara CM, Taylor KS, Haworth K, Hutchings CL, Cargill T, Angus B, Klenerman P, Pollard AJ.

J Infect. 2019 May;78(5):382-392. doi: 10.1016/j.jinf.2019.02.003. Epub 2019 Feb 8.

PMID:
30742894
3.

A Novel Vaccine Strategy Employing Serologically Different Chimpanzee Adenoviral Vectors for the Prevention of HIV-1 and HCV Coinfection.

Hartnell F, Brown A, Capone S, Kopycinski J, Bliss C, Makvandi-Nejad S, Swadling L, Ghaffari E, Cicconi P, Del Sorbo M, Sbrocchi R, Esposito I, Vassilev V, Marriott P, Gardiner CM, Bannan C, Bergin C, Hoffmann M, Turner B, Nicosia A, Folgori A, Hanke T, Barnes E, Dorrell L.

Front Immunol. 2019 Jan 18;9:3175. doi: 10.3389/fimmu.2018.03175. eCollection 2018.

4.

Publisher Correction: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2019 Mar;25(3):530. doi: 10.1038/s41591-019-0369-7.

PMID:
30705421
5.

Methylome of human senescent hematopoietic progenitors.

Capone S, Colombo AR, Johnson BK, Triche TJ Jr, Ramsingh G.

Exp Hematol Oncol. 2018 Dec 21;7:32. doi: 10.1186/s40164-018-0123-8. eCollection 2018.

6.

Antigen-specific CD8 T cells in cell cycle circulate in the blood after vaccination.

Simonetti S, Natalini A, Folgori A, Capone S, Nicosia A, Santoni A, Di Rosa F.

Scand J Immunol. 2019 Feb;89(2):e12735. doi: 10.1111/sji.12735. Epub 2019 Jan 15.

PMID:
30488973
7.

Safety and Immunogenicity of a Heterologous Prime-Boost Ebola Virus Vaccine Regimen in Healthy Adults in the United Kingdom and Senegal.

Venkatraman N, Ndiaye BP, Bowyer G, Wade D, Sridhar S, Wright D, Powlson J, Ndiaye I, Dièye S, Thompson C, Bakhoum M, Morter R, Capone S, Del Sorbo M, Jamieson S, Rampling T, Datoo M, Roberts R, Poulton I, Griffiths O, Ballou WR, Roman F, Lewis DJM, Lawrie A, Imoukhuede E, Gilbert SC, Dieye TN, Ewer KJ, Mboup S, Hill AVS.

J Infect Dis. 2019 Apr 8;219(8):1187-1197. doi: 10.1093/infdis/jiy639.

8.

Screening for active and latent tuberculosis among asylum seekers in Italy: A retrospective cohort analysis.

Pontarelli A, Marchese V, Scolari C, Capone S, El-Hamad I, Donato F, Moioli R, Girardi E, Cirillo DM, Castelli F, Matteelli A.

Travel Med Infect Dis. 2019 Jan - Feb;27:39-45. doi: 10.1016/j.tmaid.2018.10.015. Epub 2018 Oct 19.

PMID:
30347248
9.

Antibodies in lymphocyte supernatants can distinguish between neutralising antibodies induced by RSV vaccination and pre-existing antibodies induced by natural infection.

Gerretsen HE, Capone S, Vitelli A, Reyes LS, Thompson A, Jones C, Green CA, Pollard AJ, Sande CJ.

Vaccine. 2018 Nov 12;36(46):6988-6994. doi: 10.1016/j.vaccine.2018.09.070. Epub 2018 Oct 11.

PMID:
30318168
10.

Humoral and cellular immunity to RSV in infants, children and adults.

Green CA, Sande CJ, de Lara C, Thompson AJ, Silva-Reyes L, Napolitano F, Pierantoni A, Capone S, Vitelli A, Klenerman P, Pollard AJ.

Vaccine. 2018 Oct 1;36(41):6183-6190. doi: 10.1016/j.vaccine.2018.08.056. Epub 2018 Aug 31.

PMID:
30177258
11.

Implementation of tuberculosis prevention for exposed children, Burkina Faso.

Sulis G, Combary A, Getahun H, Gnanou S, Giorgetti PF, Konseimbo A, Capone S, Hamada Y, Baddeley A, Matteelli A.

Bull World Health Organ. 2018 Jun 1;96(6):386-392. doi: 10.2471/BLT.17.201343. Epub 2018 Apr 20.

12.

Understanding metabolic changes in aging bone marrow.

Connor KM, Hsu Y, Aggarwal PK, Capone S, Colombo AR, Ramsingh G.

Exp Hematol Oncol. 2018 May 23;7:13. doi: 10.1186/s40164-018-0105-x. eCollection 2018.

13.

Induction and Maintenance of CX3CR1-Intermediate Peripheral Memory CD8+ T Cells by Persistent Viruses and Vaccines.

Gordon CL, Lee LN, Swadling L, Hutchings C, Zinser M, Highton AJ, Capone S, Folgori A, Barnes E, Klenerman P.

Cell Rep. 2018 Apr 17;23(3):768-782. doi: 10.1016/j.celrep.2018.03.074.

14.

Erratum: The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Apr 10;24(4):526. doi: 10.1038/nm0418-526b.

PMID:
29634680
15.

Senescent human hematopoietic progenitors show elevated expression of transposable elements and inflammatory genes.

Capone S, Connor KM, Colombo A, Li X, Triche TJ Jr, Ramsingh G.

Exp Hematol. 2018 Jun;62:33-38.e6. doi: 10.1016/j.exphem.2018.03.003. Epub 2018 Mar 13.

PMID:
29549053
16.

Policies and practices on the programmatic management of LTBI: a survey in the African Region.

Sulis G, Carvalho ACC, Capone S, Hamada Y, Giorgetti PF, da Silva Martins P, Getahun H, Matteelli A.

Int J Tuberc Lung Dis. 2018 Feb 1;22(2):158-164. doi: 10.5588/ijtld.17.0563.

PMID:
29506611
17.

The molecular landscape of pediatric acute myeloid leukemia reveals recurrent structural alterations and age-specific mutational interactions.

Bolouri H, Farrar JE, Triche T Jr, Ries RE, Lim EL, Alonzo TA, Ma Y, Moore R, Mungall AJ, Marra MA, Zhang J, Ma X, Liu Y, Liu Y, Auvil JMG, Davidsen TM, Gesuwan P, Hermida LC, Salhia B, Capone S, Ramsingh G, Zwaan CM, Noort S, Piccolo SR, Kolb EA, Gamis AS, Smith MA, Gerhard DS, Meshinchi S.

Nat Med. 2018 Jan;24(1):103-112. doi: 10.1038/nm.4439. Epub 2017 Dec 11. Erratum in: Nat Med. 2018 Apr 10;24(4):526. Nat Med. 2019 Mar;25(3):530.

18.

Incidence and Risk Factors for Hepatitis C Virus Infection among Illicit Drug Users in Italy.

Spada E, Rezza G, Garbuglia AR, Lombardo FL, Zuccaro O, Menniti Ippolito F, Cupellaro E, Capone S, Capobianchi MR, Nicosia A, Cortese R, Folgori A, Mele A; Collaborative Study Group.

J Urban Health. 2018 Feb;95(1):99-110. doi: 10.1007/s11524-017-0207-5.

19.

Chromatographic analysis of VOC patterns in exhaled breath from smokers and nonsmokers.

Capone S, Tufariello M, Forleo A, Longo V, Giampetruzzi L, Radogna AV, Casino F, Siciliano P.

Biomed Chromatogr. 2018 Apr;32(4). doi: 10.1002/bmc.4132. Epub 2017 Dec 12.

PMID:
29131420
20.

Chimpanzee adenoviral vectors as vaccines - challenges to move the technology into the fast lane.

Vitelli A, Folgori A, Scarselli E, Colloca S, Capone S, Nicosia A.

Expert Rev Vaccines. 2017 Dec;16(12):1241-1252. doi: 10.1080/14760584.2017.1394842. Epub 2017 Oct 30. Review.

PMID:
29047309
21.

Effectiveness and cost-effectiveness of screening migrants for active tuberculosis and latent tuberculous infection.

Zenner D, Hafezi H, Potter J, Capone S, Matteelli A.

Int J Tuberc Lung Dis. 2017 Sep 1;21(9):965-976. doi: 10.5588/ijtld.16.0935. Review.

PMID:
28826445
22.

Tuberculosis elimination and the challenge of latent tuberculosis.

Matteelli A, Sulis G, Capone S, D'Ambrosio L, Migliori GB, Getahun H.

Presse Med. 2017 Mar;46(2 Pt 2):e13-e21. doi: 10.1016/j.lpm.2017.01.015. Epub 2017 Mar 6. Review.

PMID:
28279508
23.

Highly-Immunogenic Virally-Vectored T-cell Vaccines Cannot Overcome Subversion of the T-cell Response by HCV during Chronic Infection.

Swadling L, Halliday J, Kelly C, Brown A, Capone S, Ansari MA, Bonsall D, Richardson R, Hartnell F, Collier J, Ammendola V, Del Sorbo M, Von Delft A, Traboni C, Hill AV, Colloca S, Nicosia A, Cortese R, Klenerman P, Folgori A, Barnes E.

Vaccines (Basel). 2016 Aug 2;4(3). pii: E27. doi: 10.3390/vaccines4030027.

24.

New Antituberculosis Drugs: From Clinical Trial to Programmatic Use.

Gualano G, Capone S, Matteelli A, Palmieri F.

Infect Dis Rep. 2016 Jun 24;8(2):6569. doi: 10.4081/idr.2016.6569. eCollection 2016 Jun 24. Review.

25.

The Holy Grail of prevention of sexually transmitted infections in travellers.

Matteelli A, Capone S.

Sex Transm Infect. 2016 Sep;92(6):405-6. doi: 10.1136/sextrans-2016-052573. Epub 2016 Jun 6. No abstract available.

PMID:
27272531
26.

Antibody response to respiratory syncytial virus infection in children <18 months old.

Esposito S, Scarselli E, Lelii M, Scala A, Vitelli A, Capone S, Fornili M, Biganzoli E, Orenti A, Nicosia A, Cortese R, Principi N.

Hum Vaccin Immunother. 2016 Jul 2;12(7):1700-6. doi: 10.1080/21645515.2016.1145847. Epub 2016 Feb 22.

27.

Adenoviral Vector Vaccination Induces a Conserved Program of CD8(+) T Cell Memory Differentiation in Mouse and Man.

Bolinger B, Sims S, Swadling L, O'Hara G, de Lara C, Baban D, Saghal N, Lee LN, Marchi E, Davis M, Newell E, Capone S, Folgori A, Barnes E, Klenerman P.

Cell Rep. 2015 Nov 24;13(8):1578-88. doi: 10.1016/j.celrep.2015.10.034. Epub 2015 Nov 12.

28.

Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.

Callendret B, Eccleston HB, Satterfield W, Capone S, Folgori A, Cortese R, Nicosia A, Walker CM.

Hepatology. 2016 May;63(5):1442-54. doi: 10.1002/hep.28309. Epub 2015 Dec 18.

29.

Safety and immunogenicity of novel respiratory syncytial virus (RSV) vaccines based on the RSV viral proteins F, N and M2-1 encoded by simian adenovirus (PanAd3-RSV) and MVA (MVA-RSV); protocol for an open-label, dose-escalation, single-centre, phase 1 clinical trial in healthy adults.

Green CA, Scarselli E, Voysey M, Capone S, Vitelli A, Nicosia A, Cortese R, Thompson AJ, Sande CS, de Lara C, Klenerman P, Pollard AJ.

BMJ Open. 2015 Oct 28;5(10):e008748. doi: 10.1136/bmjopen-2015-008748.

30.

Chronic hepatitis C viral infection subverts vaccine-induced T-cell immunity in humans.

Kelly C, Swadling L, Capone S, Brown A, Richardson R, Halliday J, von Delft A, Oo Y, Mutimer D, Kurioka A, Hartnell F, Collier J, Ammendola V, Del Sorbo M, Grazioli F, Esposito ML, Di Marco S, Siani L, Traboni C, Hill AV, Colloca S, Nicosia A, Cortese R, Folgori A, Klenerman P, Barnes E.

Hepatology. 2016 May;63(5):1455-70. doi: 10.1002/hep.28294. Epub 2016 Jan 22.

31.

Combining Protein and Strain Engineering for the Production of Glyco-Engineered Horseradish Peroxidase C1A in Pichia pastoris.

Capone S, Ćorajević L, Bonifert G, Murth P, Maresch D, Altmann F, Herwig C, Spadiut O.

Int J Mol Sci. 2015 Sep 24;16(10):23127-42. doi: 10.3390/ijms161023127.

32.

Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.

Taylor G, Thom M, Capone S, Pierantoni A, Guzman E, Herbert R, Scarselli E, Napolitano F, Giuliani A, Folgori A, Colloca S, Cortese R, Nicosia A, Vitelli A.

Sci Transl Med. 2015 Aug 12;7(300):300ra127. doi: 10.1126/scitranslmed.aac5757.

PMID:
26268314
33.

Chimpanzee adenovirus- and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.

Green CA, Scarselli E, Sande CJ, Thompson AJ, de Lara CM, Taylor KS, Haworth K, Del Sorbo M, Angus B, Siani L, Di Marco S, Traboni C, Folgori A, Colloca S, Capone S, Vitelli A, Cortese R, Klenerman P, Nicosia A, Pollard AJ.

Sci Transl Med. 2015 Aug 12;7(300):300ra126. doi: 10.1126/scitranslmed.aac5745.

34.

CD161(int)CD8+ T cells: a novel population of highly functional, memory CD8+ T cells enriched within the gut.

Fergusson JR, Hühn MH, Swadling L, Walker LJ, Kurioka A, Llibre A, Bertoletti A, Holländer G, Newell EW, Davis MM, Sverremark-Ekström E, Powrie F, Capone S, Folgori A, Barnes E, Willberg CB, Ussher JE, Klenerman P.

Mucosal Immunol. 2016 Mar;9(2):401-13. doi: 10.1038/mi.2015.69. Epub 2015 Jul 29.

35.

Development of a mixed feed strategy for a recombinant Pichia pastoris strain producing with a de-repression promoter.

Capone S, Horvat J, Herwig C, Spadiut O.

Microb Cell Fact. 2015 Jul 10;14:101. doi: 10.1186/s12934-015-0292-7.

36.

Mucosal delivery of a vectored RSV vaccine is safe and elicits protective immunity in rodents and nonhuman primates.

Pierantoni A, Esposito ML, Ammendola V, Napolitano F, Grazioli F, Abbate A, Del Sorbo M, Siani L, D'Alise AM, Taglioni A, Perretta G, Siccardi A, Soprana E, Panigada M, Thom M, Scarselli E, Folgori A, Colloca S, Taylor G, Cortese R, Nicosia A, Capone S, Vitelli A.

Mol Ther Methods Clin Dev. 2015 May 20;2:15018. doi: 10.1038/mtm.2015.18. eCollection 2015.

37.

Antibacterial activity of enrofloxacin and ciprofloxacin derivatives of β-octaarginine.

Purkayastha N, Capone S, Beck AK, Seebach D, Leeds J, Thompson K, Moser HE.

Chem Biodivers. 2015 Feb;12(2):179-93. doi: 10.1002/cbdv.201400456.

PMID:
25676502
38.

Optimizing cofactor availability for the production of recombinant heme peroxidase in Pichia pastoris.

Krainer FW, Capone S, Jäger M, Vogl T, Gerstmann M, Glieder A, Herwig C, Spadiut O.

Microb Cell Fact. 2015 Jan 13;14:4. doi: 10.1186/s12934-014-0187-z.

39.

A human vaccine strategy based on chimpanzee adenoviral and MVA vectors that primes, boosts, and sustains functional HCV-specific T cell memory.

Swadling L, Capone S, Antrobus RD, Brown A, Richardson R, Newell EW, Halliday J, Kelly C, Bowen D, Fergusson J, Kurioka A, Ammendola V, Del Sorbo M, Grazioli F, Esposito ML, Siani L, Traboni C, Hill A, Colloca S, Davis M, Nicosia A, Cortese R, Folgori A, Klenerman P, Barnes E.

Sci Transl Med. 2014 Nov 5;6(261):261ra153. doi: 10.1126/scitranslmed.3009185.

40.

Cross-reactivity of hepatitis C virus specific vaccine-induced T cells at immunodominant epitopes.

Kelly C, Swadling L, Brown A, Capone S, Folgori A, Salio M, Klenerman P, Barnes E.

Eur J Immunol. 2015 Jan;45(1):309-16. doi: 10.1002/eji.201444686. Epub 2014 Oct 30.

41.

A structural and spectroscopic investigation of octahedral platinum bis(dithiolene)phosphine complexes: platinum dithiolene internal redox chemistry induced by phosphine association.

Chandrasekaran P, Greene AF, Lillich K, Capone S, Mague JT, DeBeer S, Donahue JP.

Inorg Chem. 2014 Sep 2;53(17):9192-205. doi: 10.1021/ic501273b. Epub 2014 Aug 12.

PMID:
25113575
42.

Safety and tolerability of conserved region vaccines vectored by plasmid DNA, simian adenovirus and modified vaccinia virus ankara administered to human immunodeficiency virus type 1-uninfected adults in a randomized, single-blind phase I trial.

Hayton EJ, Rose A, Ibrahimsa U, Del Sorbo M, Capone S, Crook A, Black AP, Dorrell L, Hanke T.

PLoS One. 2014 Jul 9;9(7):e101591. doi: 10.1371/journal.pone.0101591. eCollection 2014.

43.

T-cell immunity and hepatitis C virus reinfection after cure of chronic hepatitis C with an interferon-free antiviral regimen in a chimpanzee.

Callendret B, Eccleston HB, Hall S, Satterfield W, Capone S, Folgori A, Cortese R, Nicosia A, Walker CM.

Hepatology. 2014 Nov;60(5):1531-40. doi: 10.1002/hep.27278. Epub 2014 Sep 25.

44.

Enhanced vaccine-induced CD8+ T cell responses to malaria antigen ME-TRAP by fusion to MHC class ii invariant chain.

Spencer AJ, Cottingham MG, Jenks JA, Longley RJ, Capone S, Colloca S, Folgori A, Cortese R, Nicosia A, Bregu M, Hill AV.

PLoS One. 2014 Jun 19;9(6):e100538. doi: 10.1371/journal.pone.0100538. eCollection 2014.

45.

Glyco-variant library of the versatile enzyme horseradish peroxidase.

Capone S, Pletzenauer R, Maresch D, Metzger K, Altmann F, Herwig C, Spadiut O.

Glycobiology. 2014 Sep;24(9):852-63. doi: 10.1093/glycob/cwu047. Epub 2014 May 23.

46.

Combined adenovirus vector and hepatitis C virus envelope protein prime-boost regimen elicits T cell and neutralizing antibody immune responses.

Chmielewska AM, Naddeo M, Capone S, Ammendola V, Hu K, Meredith L, Verhoye L, Rychlowska M, Rappuoli R, Ulmer JB, Colloca S, Nicosia A, Cortese R, Leroux-Roels G, Balfe P, Bienkowska-Szewczyk K, Meuleman P, McKeating JA, Folgori A.

J Virol. 2014 May;88(10):5502-10. doi: 10.1128/JVI.03574-13. Epub 2014 Mar 5.

47.

Fusion of HCV nonstructural antigen to MHC class II-associated invariant chain enhances T-cell responses induced by vectored vaccines in nonhuman primates.

Capone S, Naddeo M, D'Alise AM, Abbate A, Grazioli F, Del Gaudio A, Del Sorbo M, Esposito ML, Ammendola V, Perretta G, Taglioni A, Colloca S, Nicosia A, Cortese R, Folgori A.

Mol Ther. 2014 May;22(5):1039-47. doi: 10.1038/mt.2014.15. Epub 2014 Jan 30.

48.

Fe3O4/γ-Fe2O3 nanoparticle multilayers deposited by the Langmuir-Blodgett technique for gas sensors application.

Capone S, Manera MG, Taurino A, Siciliano P, Rella R, Luby S, Benkovicova M, Siffalovic P, Majkova E.

Langmuir. 2014 Feb 4;30(4):1190-7. doi: 10.1021/la404542u. Epub 2014 Jan 21.

PMID:
24410195
49.

Subinfectious hepatitis C virus exposures suppress T cell responses against subsequent acute infection.

Park SH, Veerapu NS, Shin EC, Biancotto A, McCoy JP, Capone S, Folgori A, Rehermann B.

Nat Med. 2013 Dec;19(12):1638-42. doi: 10.1038/nm.3408. Epub 2013 Nov 24.

50.

Microbials for the production of monoclonal antibodies and antibody fragments.

Spadiut O, Capone S, Krainer F, Glieder A, Herwig C.

Trends Biotechnol. 2014 Jan;32(1):54-60. doi: 10.1016/j.tibtech.2013.10.002. Epub 2013 Oct 31. Review.

Supplemental Content

Loading ...
Support Center